These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22677751)

  • 1. [The use of cerepro (choline alfoscerate) in the treatment of outpatients with chronic progressive cerebrovascular disease].
    Kostenko EV; Petrova LV; Artemova IIu; Vdovichenko TV; Ganzhula PA; Ismailov AM; Lisenker LN; Petrov SV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):24-30. PubMed ID: 22677751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The experience of the use of cerepro in the treatment of out-patients in the early period of rehabilitation of is ischemic stroke.].
    Boĭko AN; Batysheva TT; Bagir' LV; Kostenko EV; Matvievskaia OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(10):34-40. PubMed ID: 18477977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of cereton in the acute period of ischemic stroke].
    Ismagilov MF; Vasilevskaia OV; Gaĭfutdinov RT; Strakhova TM; Kuz'mina IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):35-6. PubMed ID: 19365389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome].
    Kamilov KМ; Kasimova MS; Makhkamova DК
    Vestn Oftalmol; 2016; 132(2):73-76. PubMed ID: 27213801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
    Parnetti L; Amenta F; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicardipine in the treatment of outpatients with cerebrovascular disorders.
    Lozano R; Balaguer A
    Clin Ther; 1991; 13(4):496-9. PubMed ID: 1934002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of cholinomimetics in the treatment of endogenous autism in children].
    Krasnoperova MG; Simashkova NV; Bashina VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):35-9. PubMed ID: 15285632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of choline alfoscerate in the preventive therapy of dementia in elderly patients with Mild Cognitive Impairment: a three-year prospective comparative study].
    Ponomareva EV; Androsova LV; Krinsky SA; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4. Vyp. 2):92-99. PubMed ID: 38696157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of the drug ginos in the treatment of out-patients with chronic progressive brain disorders].
    Batysheva TT; Bagir' LV; Kostenko EV; Artemova IIu; Vdovichenko TV; Ganzhula PA; Zhuravleva EIu; Ismailov AM; Lisenker LN; Nesterova OV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):55-9. PubMed ID: 18379464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment].
    Pizova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):78-83. PubMed ID: 25726784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
    Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined therapy of cerebrovascular disorders with neuroprotectors].
    Putilina MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):58-63. PubMed ID: 28091502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of choline alfoscerate (gliatiline) in patients with ischemic stroke].
    Vinogradov OI; Daminov VD; Rybalko NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):43-5. PubMed ID: 23528493
    [No Abstract]   [Full Text] [Related]  

  • 15. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Alzheimers Dis; 2014; 42 Suppl 3():S281-8. PubMed ID: 24898643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experience of using divasa in the treatment of cerebrovascular insufficiency].
    Chukanova EI; Bogolepova AN; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):17-23. PubMed ID: 26356393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
    Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):35-9. PubMed ID: 19770831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary evaluation of risk and effectiveness of early choline alphoscerate treatment in craniocerebral injury].
    Mandat T; Wilk A; Manowiec R; Koziarski A; Zieliński G; Podgórski JK
    Neurol Neurochir Pol; 2003; 37(6):1231-8. PubMed ID: 15174236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of cortexin in neurological practice for treatment of out-patients with chronic cerebrovascular disturbances].
    Boĭko AN; Batysheva TT; Vinetskiĭ IaIa; Vdovichenko TV; Ganzhula PA; Gaponova OV; Zhuravleva EIu; Ismailov AM; Lisneker LN; Otcheskaia OV; Khozova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):25-30. PubMed ID: 16768221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.